Premium
Assessment of Infantile Hemangiomas Using a Handheld Wireless Diffuse Optical Spectroscopic Device
Author(s) -
Fong Christopher J.,
Garzon Maria C.,
Hoi Jennifer W.,
Kim Hyun K.,
Lauren Christine T.,
Morel Kimberly,
Geller Lauren,
Antonov Nina,
Weitz Nicole,
Wu June,
Hielscher Andreas H.
Publication year - 2017
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13150
Subject(s) - medicine , vascularity , lesion , hemangioma , propranolol , surgery
Background/Objectives Infantile hemangiomas ( IH s) are vascular tumors with the potential for significant morbidity. There is a lack of validated objective tools to assess IH severity and response to treatment. Diffuse optical spectroscopy ( DOS ), a noninvasive, nonionizing imaging modality, can measure total hemoglobin concentration and hemoglobin oxygen saturation in tissue to assess IH vascularity and response to treatment. Our objective was to evaluate the utility of a wireless, handheld DOS system to assess IH characteristics at selected points during their clinical course. Methods Thirteen subjects (initial age 5.8 ± 2.0 mos) with 15 IH s were enrolled. IH s were classified as proliferative, plateau phase, or involuting. Nine patients with 11 IH s were untreated; four patients with 4 IH s were treated with timolol or propranolol. Each IH was evaluated by placing the DOS system directly on the lesion as well a normal contralateral skin site. IH vascularity and oxygenation were scored using a newly defined normalized hypoxia fraction ( NHF ) coefficient. Measurements were recorded at various intervals from the initial visit to 1 to 2 years of age. Results For the nine untreated IH s, the NHF was highest at 6 months of age, during proliferation. Differences in NHF s between the proliferation and the plateau (p = 0.02) and involuting (p < 0.001) stages were statistically significant. In treated patients, the NHF normalized to 60% after 2 months. One treated IH came within 5% of the NHF for normal skin after 12 months. Conclusions DOS can be used to assess the vascularity and tissue oxygenation of IH s and monitor their progression and response to treatment.